MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
The current MacroGenics(MGNX) stock price is $3.33, with a market capitalization of 211.8M. The stock trades at a price-to-earnings (P/E) ratio of -14.11.
During the trading session on 2026-10-19, MacroGenics(MGNX) shares reached a daily high of $3.44 and a low of $3.26. At a current price of $3.33, the stock is +2.0% higher than the low and still -3.2% under the high.
Trading volume for MacroGenics(MGNX) stock has reached 366.33K, versus its average volume of 567.5K.
The stock's 52-week range extends from a low of $1.29 to a high of $5.08.
The stock's 52-week range extends from a low of $1.29 to a high of $5.08.
MGNX News
MacroGenics (MGNX) announced that the first patient has been dosed in the Phase 1 study of MGC030, an antibody-drug conjugate directed against an undisclosed ta...
Analyst ratings
50%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.